Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2022-11-14

Clinical Trial Update: A Randomized Controlled Cost Study of Infuse BMP 2 vs Iliac Crest Autograft for Non Union of Long Bone Fractures [Phase 4]

View source ↗

Summary

Phase 4 trial comparing Infuse BMP 2 to iliac crest autograft for nonunion long bone fractures was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Infuse BMP-2 (bone morphogenetic protein-2)

Snippet

Sponsor: Ross Leighton | Conditions: Non Union Diaphyseal Fractures | Phase 4 | Status: WITHDRAWN